Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Revaree Plus in Women With Breast Cancer
NCT07042581Phase 4Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2025
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in vaginal dryness and dyspareunia, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Vaginal Assessment Scale at 8 weeks. Started Jun 2025; status: recruiting.
02
Conditions
vaginal drynessdyspareunia
Beyond the preview
Go deeper on NCT07042581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07042581.